Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. ARS Other Annual Report to Security Holders
  7. 3 Insider Initial Statement of Ownership
  8. SCHEDULE 13D Stake Beneficial Ownership Report
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
  20. 4 Insider Changes in Ownership

Page 3 of 21 · 404 filings